The aim of this study was to examine whether the urinary Gal-3 level is also a useful biomarker enabling the accurate prediction of the risk of kidney disease progression, which could help clinicians to early initiate renoprotective strategies to slow such progression. Here, LGALS3 is linked to kidney disorder.